Lineage Cell Therapeutics (LCTX) Earnings Date & Reports

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LCTX is expected to report earnings to rise 35.50% to -2 cents per share on August 07

Lineage Cell Therapeutics LCTX Stock Earnings Reports

Q2'25

Est.

$-0.03

Q1'25

Beat

by $0.01

Q4'24

Beat

by $0.01

Q3'24

Beat

by $0.02

Q2'24

Beat

by $0.02

The last earnings report on May 13 showed earnings per share of -1 cents, beating the estimate of -2 cents. With 23.66M shares outstanding, the current market capitalization sits at 213.56M.

View a ticker or compare two or three

Compare

LCTX